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DOI: 10.1183/09031936.00055509. [Prepared by Mark 
Elkins, CAP Editor.]
Question: Does regular airway clearance using an oscillating 
positive expiratory pressure (PEP) device improve 
quality of life, sputum volume, respiratory function, and 
exercise capacity in people with bronchiectasis? Design: 
Randomised, crossover, controlled trial with 3-month 
intervention periods separated by a 1-month washout period. 
Setting: Acute teaching hospital in Scotland. Participants: 
20 adults with radiologically diagnosed bronchiectasis and 
chronic sputum expectoration, who were not performing 
regular physiotherapy for airway clearance. Smoking, 
asthma, emphysema, and cystic fibrosis were exclusion 
criteria. Interventions: While in the intervention arm, 
participants performed 20–30 minutes of airway clearance 
twice daily. Each session consisted of three cycles of 10 
breaths through an oscillating positive expiratory pressure 
(PEP) device called the Acapella, followed by the forced 
expiratory technique and coughing. Each participant’s 
technique was reviewed by a physiotherapist monthly during 
the intervention arm. During the control arm, the device was 
retained by the investigators and participants performed 
no physiotherapy for airway clearance. Throughout the 
study, both groups received all other standard management 
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including antibiotics when exacerbation criteria were met. 
Any changes to the participants’ usual medication regimen 
were noted. Outcome measures: The primary outcome was 
the Leicester Cough Questionnaire (LCQ) – a 19-point, 
patient-reported measure of the impact of cough severity on 
quality of life with three domains (physical, psychological, 
and social). Secondary outcomes included the St George’s 
Respiratory Questionnaire (SGRQ), 24-hour sputum 
volume, lung function, maximum respiratory pressures, 
and the incremental shuttle walk test, measured at the 
end of each intervention arm. Results: All participants 
completed the study with no adverse events during airway 
clearance. During the 3-month intervention period, the total 
LCQ score showed significantly greater improvement than 
during the control period: difference in medians for total 
LCQ score 1.3 points, p = 0.002. Each of the three domains 
within the LCQ also showed significant benefits. Other 
outcomes that showed significantly greater improvements 
due to the airway clearance intervention were the SGRQ 
(difference in medians 8.5 points, p = 0.005), 24-hr sputum 
volume (difference in medians 3 ml, p = 0.02), and the 
incremental shuttle walk distance (difference in medians 40 
m, p = 0.001). The groups did not differ significantly on 
the remaining secondary outcomes. Conclusion: Regular 
airway clearance with oscillating PEP improves disease-
related quality of life and exercise capacity in people with 
bronchiectasis.
Commentary
This is the first long-term randomised trial of airway 
clearance physiotherapy in bronchiectasis. Previous short-
term trials have only identified improvements in measures 
of sputum clearance (Jones & Rowe 2005). Long-term 
changes in sputum production are difficult to interpret 
because, while an increase may indicate more effective 
clearance, it could also indicate a greater mucus load in 
the lungs. So, while Murray and colleagues identified an 
effect on 24-hr sputum volume, of greater importance are 
the improvements in quality of life and incremental walk 
test distance.
The trial was well designed. The use of a crossover 
design raises concerns about carryover effects. Although 
the authors report similar group characteristics before 
intervention periods 1 and 2, it would be more convincing 
to report similarity before treatment and control periods 
(eg, Hodgson et al 2007). The breathing regimen employed 
with the Acapella (3 sets of 10 breaths) was a small 
treatment stimulus compared to the 10 sets of 10 breaths 
utilised in traditional PEP therapy (Elkins et al 2006), even 
considering it was applied twice a day. Also, an advantage 
of the Acapella is its ability to provide oscillating PEP 
independent of gravity, but it is unclear whether this was 
utilised because the position of the participants was not 
described.
Despite the above issues, this paper provides much 
needed evidence to support the use of airway clearance 
physiotherapy as a maintenance strategy in this population. 
The worthwhile results in this mild patient group show 
that initiating airway clearance physiotherapy early in the 
disease process is appropriate. Patients with greater sputum 
production may have more to gain, so further trials with 
participants with more severe disease should be conducted. 
Such trials should employ blinded outcome assessment and 
a stronger treatment stimulus. Also, given the recent trend 
for measures of global satisfaction with treatment to be 
included in clinical trials (eg, Glinksy et al 2008, Kay et al 
2008, Lau et al 2008), this could be reported, as could the 
proportion of participants who elect to continue with the 
intervention after completing the trial.
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